Haloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: Increased plasma levels of the reduced metabolite in poor metabolizers - LLerena,A.; Dahl,M.L.; Ekqvist,B.; Bertilsson,L. (Therapeutic Drug Monitoring, 1992)